Page last updated: 2024-10-16

carbamates and Brain Injuries

carbamates has been researched along with Brain Injuries in 7 studies

Brain Injuries: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.

Research Excerpts

ExcerptRelevanceReference
" Whether repeated dosing would achieve greater protection remains to be examined."1.42Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury. ( Impastato, RA; Katz, PS; Molina, PE; Rogers, EK; Sulzer, JK; Teng, SX, 2015)
" The effect of SNJ-1945 on α-spectrin degradation exhibited a U-shaped dose-response curve when treatment was initiated 15 min post-TBI."1.39Pharmacological analysis of the cortical neuronal cytoskeletal protective efficacy of the calpain inhibitor SNJ-1945 in a mouse traumatic brain injury model. ( Bains, M; Barnes, CC; Cebak, JE; Geddes, JW; Gilmer, LK; Hall, ED; Thompson, SN, 2013)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's4 (57.14)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Ren, J1
Guo, J1
Zhu, S1
Wang, Q1
Gao, R1
Zhao, C1
Feng, C1
Qin, C2
He, Z1
Wang, Z1
Zang, L1
Li, GB1
Liu, JY1
Feng, XM1
Zhang, BL1
Zhang, RS1
Katz, PS1
Sulzer, JK1
Impastato, RA1
Teng, SX1
Rogers, EK1
Molina, PE1
Tchantchou, F1
Zhang, Y1
Bains, M1
Cebak, JE1
Gilmer, LK1
Barnes, CC1
Thompson, SN1
Geddes, JW1
Hall, ED1
Keck, CA1
Thompson, HJ1
Pitkänen, A1
LeBold, DG1
Morales, DM1
Plevy, JB1
Puri, R1
Zhao, B1
Dichter, M1
McIntosh, TK1
Blount, PJ1
Nguyen, CD1
McDeavitt, JT1

Reviews

1 review available for carbamates and Brain Injuries

ArticleYear
Clinical use of cholinomimetic agents: a review.
    The Journal of head trauma rehabilitation, 2002, Volume: 17, Issue:4

    Topics: Administration, Oral; Adult; Aged; Alzheimer Disease; Brain Injuries; Carbamates; Clinical Trials as

2002

Other Studies

6 other studies available for carbamates and Brain Injuries

ArticleYear
The Role of Potassium Channels in Chronic Stress-Induced Brain Injury.
    Biological & pharmaceutical bulletin, 2021, Feb-01, Volume: 44, Issue:2

    Topics: Animals; Brain; Brain Injuries; Carbamates; Disease Models, Animal; Female; Humans; Neuroprotective

2021
Retigabine attenuates focal cerebral ischemic injury through inhibiting mitochondria-dependent apoptotic pathway.
    European review for medical and pharmacological sciences, 2018, Volume: 22, Issue:15

    Topics: Animals; Apoptosis; Brain Injuries; Carbamates; Caspase 3; Disease Models, Animal; Glutathione; JNK

2018
Endocannabinoid degradation inhibition improves neurobehavioral function, blood-brain barrier integrity, and neuroinflammation following mild traumatic brain injury.
    Journal of neurotrauma, 2015, Mar-01, Volume: 32, Issue:5

    Topics: Animals; Arachidonic Acids; Benzamides; Benzodioxoles; Blood-Brain Barrier; Blotting, Western; Brain

2015
Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury.
    Journal of neurotrauma, 2013, Apr-01, Volume: 30, Issue:7

    Topics: Animals; Arachidonic Acids; Biphenyl Compounds; Blood-Brain Barrier; Blotting, Western; Brain Injuri

2013
Pharmacological analysis of the cortical neuronal cytoskeletal protective efficacy of the calpain inhibitor SNJ-1945 in a mouse traumatic brain injury model.
    Journal of neurochemistry, 2013, Volume: 125, Issue:1

    Topics: Animals; Brain Injuries; Calpain; Carbamates; Cerebral Cortex; Cytoskeleton; Dose-Response Relations

2013
The novel antiepileptic agent RWJ-333369-A, but not its analog RWJ-333369, reduces regional cerebral edema without affecting neurobehavioral outcome or cell death following experimental traumatic brain injury.
    Restorative neurology and neuroscience, 2007, Volume: 25, Issue:2

    Topics: Animals; Anticonvulsants; Behavior, Animal; Brain Edema; Brain Injuries; Carbamates; Cell Death; Cog

2007